SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001346302-20-000028
Filing Date
2020-05-07
Accepted
2020-05-07 07:07:43
Documents
16
Period of Report
2020-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xers-20200507.htm   iXBRL 8-K 51214
2 EX-99.1 exh991q12020earningsre.htm EX-99.1 126238
8 xerislpharmrgba111.jpg GRAPHIC 74582
  Complete submission text file 0001346302-20-000028.txt   470185

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xers-20200507.xsd EX-101.SCH 2561
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xers-20200507_cal.xml EX-101.CAL 708
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xers-20200507_def.xml EX-101.DEF 15623
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xers-20200507_lab.xml EX-101.LAB 30040
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xers-20200507_pre.xml EX-101.PRE 16292
17 EXTRACTED XBRL INSTANCE DOCUMENT xers-20200507_htm.xml XML 11692
Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Filer) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38536 | Film No.: 20854533
SIC: 2834 Pharmaceutical Preparations